Lunch Report: Market Lifts Off 9-Week Low
The Australian sharemarket is improving in unenthusiastic buying on Thursday, with the ASX 200 up 0.7% after slumping by 2.1% on Wednesday.
Read MoreThe Australian sharemarket is improving in unenthusiastic buying on Thursday, with the ASX 200 up 0.7% after slumping by 2.1% on Wednesday.
Read MoreShares in Apple rose 4.0% with Tesla up 10.9%. Shares in ‘stay-at-home’ stocks like Facebook and Amazon also rose. Reuters reported that shares in “Tiffany & Co tumbled 6.4% after French luxury goods giant LVMH warned it was set to walk away from its planned $16 billion takeover of the US jeweller.” The Dow Jones index rose by 440 points or 1.6%. The S&P500 index lifted 2.0% and the Nasdaq index gained 294 points or 2.7%.
Read MoreNot much improved for the sharemarket this afternoon, with the ASX 200 down 2.15% due to broad losses across 90% of stocks and every sector. Weakness on Wall Street, a tumble in oil prices and negative vaccine news contributed to the losses.
Read MoreThe Australian sharemarket has easily wiped out this week’s gains, with shares hitting five-week lows. This follows a weak lead from US tech stocks, a pause in a vaccine development and a 7.5% tumble in oil prices.
Read MoreFollowing up on his wrap on Q2 Reporting Season, Martin Conlon from Schroders gives his thoughts on where some opportunities lie in the current market.
Read MoreTechnology shares extended their slide. Tesla shares lost 21.1% after being snubbed for inclusion in the S&P 500 index. Apple shares fell 6.7%, despite announcing an event on September 15 where it is expected to reveal new products.
Read MoreThe Aussie market has closed higher for a second successive session with the ASX 200 gaining 63pts or 1.1% to 6,008. Local shares fluctuated throughout the day as heavyweights again contributed most to broader moves.
Read MoreFirst Sentier Investors Senior Portfolio Manager Tim Canham discuss their substantial shareholding in renewable energy company Genex Power.
Read MoreThe Australian sharemarket is following European stocks higher, with the ASX 200 up by ~1% at lunch while the iron ore price is closing in on a six and a half year high. Most sectors are gaining.
Read MoreThe US and Canadian markets were closed overnight for the Labor Day holiday. European stocks rose by around 1.7%, with 86% of stocks finishing higher. Oil prices fell, iron ore rose and the Aussie market is set for a better start.
Read MoreAfter some big swings early in the day, the ASX 200 has managed to close higher on Monday with a gain of 19 points or 0.33% to 5945. Major banks, miners and CSL helped buoy the market as tech, retailing and industrials weighed most.
Read MoreDespite a weak lead from Wall Street on Friday and news of the lockdown extension in Victoria, the Australian sharemarket is bouncing back from Friday’s outsized 3% tumble.
Read MoreThe US sharemarket added to Thursday’s 3.5% slump with a 0.8% decline for the S&P 500 on Friday. Questions are being asked of the tech stocks, with the five largest US companies still up by as much as 80% in 2020.
Read MoreThe local market fell by 3% on Friday due to the largest tumble in 3 months in the US. Tech giants like Apple, Amazon and Facebook which have been driving US stocks to record highs slumped.
Read MoreQ2 2020 reporting season for Australian equities has come and gone. What does that mean for investors? Who were the winners and losers? Martin Conlon, Head of Australian Equities at Schroders, gives some insights.
Read MoreMarley Spoon has been operating for 6 years and currently generates half a billion in AUD$ in runway revenue, it achieved positive operating cash flow in H1 2020 and became profitable in Q2 this year. ShareCafe spoke with CEO Fabien Siegel.
Read MoreThe Aussie market is a sea of red as it follows a tech-led sell off on Wall Street. Towards lunch, the ASX 200 index is down roughly 2.5% and suffering one of its worst days since June. Tech stocks are falling hardest.
Read MoreThe rotation away from technology stocks gained momentum as investors questioned the sustainability of lofty valuations. Apple shares fell 8%. Shares of Amazon (-4.6%), Netflix (-4.9%) and Facebook (-3.8%) all plunged.
Read MoreThe Aussie market has notched a second straight day of gains with the ASX 200 lifting 50 points or 0/8% and closed above 6,100 for the first time in a week. Financials, retailers and health stocks led improvements while miners and tech stocks lagged.
Read MoreThe Aussie market is lifting for a second day with the ASX 200 around intraday highs at lunch. The banks are adding most to improvements while BNPL stocks are rebounding from recent declines. Mining & tech names are leading the declines.
Read MoreSo-called ‘defensive’ areas of the market did well including utilities, consumer staples, and real estate. The Dow Jones index rose by 455 points or 1.6%. The S&P500 index lifted by 1.5% and the Nasdaq index rose by 117 points or 1.0% – both closing at record highs.
Read MoreThe Aussie market improved further this afternoon, with the ASX 200 lifting by 1.8% thanks to gains across all sectors and 87% of stocks.
Read MoreThe Australian sharemarket is lifting by 1.5% at lunch, recouping most of Tuesday’s decline and bouncing off yesterday’s one-month low. Australia’s economy contracted by 7% over the June quarter.
Read MoreSolid factory data fuelled optimism about the US economic recovery. Apple shares rose 4% on reports of orders for 75 million 5G iPhones later this year. Shares of Zoom Video surged 40.8% after it raised its annual revenue forecast by over 30%.
Read MoreThe Aussie market has suffered its worst declines in over a month with the ASX 200 tumbling 107 points or 1.8% to 5,953 on broad selling. Every sector closed in the red with financials, technology and consumer staples among the worst performers. Defensive names such as utilities and gold stocks were among the few winners.
Read MoreThe Agency Group (ASX:AU1) is one of Australia’s fastest-growing integrated real estate service companies, with approximately 280 real estate agents. The company recently released their Preliminary Final Report for the full year ended 30 June 2020.
Read MoreIt has been a tough start to the new month with the ASX 200 deeply in the red. Losses have been widespread as financials, technology, energy and consumer staples weigh heavily as roughly 90% of the top 200 stocks fall. The AUD is a winner so far as it closes in on 74 US cents.
Read MoreSome investors booked profits at the end of the month. Shares in Tesla rose 12.6% and shares in Apple rose 3.4% after both companies effected stock splits.
Read MoreWhat’s former Leighton chief Wal King up to these days? He’s putting the finishing touches on an astute acquisition by bringing together Terracom Limited (ASX:TER) with Universal Coal.
Read MoreThe Aussie market has fallen on Monday in what was choppy trade. The ASX 200 fell 13 points or 0.2% to 6,060 with Fortescue’s 7.7% decline weighing most. Even with today’s losses, the ASX 200 index improved for a fifth month in a row.
Read MoreWith a number of positive macro factors driving the outlook, T. Rowe Price believes the US housing market offers a happy hunting ground for high-quality companies. Ryan Martin, Head of Research, Australian Equities, explains how James Hardie is leveraged to this theme.
Read MoreAs Australian companies have grown, so has their footprint on the global stage. This means many of the country’s best businesses are effectively global leaders in their own right and have significant operations in many countries around the world. Randall Jenneke from T. Rowe Price shares his insights with ShareCafe.
Read MorePlatinum International Healthcare Fund Manager Dr. Bianca Ogden provides a keynote presentation on ‘Innovation in Health Care’ at the ShareCafe Hidden Gems webinar.
Read MorePresenter – Sean Hall – CEO & MD – Medlab Clinical is a medical research and development facility researching and formulating novel bio-therapeutics (e.g., nutraceuticals and pharmaceuticals) to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease and pre-diabetes/obesity.
Read MorePresenter – Dr. Ross Macdonald – CEO & MD – Cynata is an Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on CymerusTM, a proprietary therapeutic stem cell platform technology.
Read MorePresenter – Daniel Kenny – CEO – OncoSil Medical is a medical device company seeking to advance radiation for cancer patients. OncoSil Medical’s lead product, OncoSilTM is a targeted radioactive isotope (Phosphorus-32), implanted directly into a patient’s pancreatic tumours via an endoscopic ultrasound. Treatment with the OncoSilTM is intended to deliver more concentrated and localised beta radiation compared to external beam radiation.
Read MorePresenter – John Melki – CEO & Director – Genetic Signatures has released a suite of real-time PCR based products for the routine detection of infectious diseases under the EasyScreen™ brand. This proprietary MDx technology provides hospitals and pathology laboratories with the ability to screen for a wide array of infectious pathogens with a high degree of specificity in a rapid throughput (time to result) environment.
Read MoreLocal shares are edging higher after a flat start to the week. Gains for energy and IT stocks are mostly being offset by losses for health and staples and Fortescue Metals (FMG). National Bank (NAB) is higher after agreeing to sell its MLC Wealth.
Read MoreWe continue to unearth small-cap companies as part of our Hidden Gems webinar series. Catch up on the full webinar with presentations from Oncosil Medical, Medlab Clinical, Cynata Therapeutics, and Genetic Signatures.
Read MoreUS sharemarkets rose on Friday with the S&P 500 and Nasdaq at record highs.
Read More